Viewing Study NCT05026502


Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2026-06-17 @ 10:39 AM
Study NCT ID: NCT05026502
Status: TERMINATED
Last Update Posted: 2023-08-14
First Post: 2021-08-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess Patient-Reported Quality of Life and Effectiveness on Control of Bleeding in Adult Participants With Heavy Menstrual Bleeding Due to Uterine Fibroids Taking Oral Oriahnn Capsules
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Heavy Menstrual Bleeding View
None Uterine Fibroids View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Elagolix View
None Estradiol/Norethindrone Acetate (E2/NETA) View
None Oriahnn View
None ABT-620 View
None Heavy Menstrual Bleeding (HMB) View
None Uterine Fibroids (UF) View